SPS

to be used interchangeably. When switching pharmaceutical forms, the dose should be adjusted to the closest milligram strength of the new pharmaceutical form and the everolimus trough concentration assessed at least 1 week later (25). Consult product literature for details of therapeutic drug monitoring. Fusidic acid ................
................